Transcriptomics

Dataset Information

0

Targeted lysosomal activation in bladder epithelium enhances clearance of intracellular uropathogenic Escherichia coli


ABSTRACT: Recurrent urinary tract infections (UTIs) are a major clinical burden, driven in part by the ability of uropathogenic Escherichia coli (UPEC) to establish intracellular niches within the bladder epithelium, where bacteria withstand antibiotics and host defenses. The oral bacterial lysate OM-89 (Uro-Vaxom), a clinically approved and globally used therapy for the prevention and management of recurrent UTIs for several decades, reduces recurrence rates, but its cellular mechanisms of action remain incompletely understood. Here, we demonstrate that OM-89 strengthens antimicrobial defenses in bladder epithelial cells and, in combination with antibiotic therapy, limits post-antibiotic regrowth in epithelial infection models. OM-89 promotes lysosomal acidification and increases lysosomal protease activity in bladder organoids and differentiated epithelial monolayers, thereby directing intracellular UPEC toward degradative compartments. In parallel, OM-89 enhances intracellular accumulation of multiple antibiotic classes. These effects are conserved across distinct UPEC strains and in both murine and human epithelial models. Our findings demonstrate that bladder epithelial antimicrobial pathways can be pharmacologically reinforced to influence treatment outcomes by enhancing intracellular bacterial clearance.

ORGANISM(S): Mus musculus

PROVIDER: GSE306613 | GEO | 2025/10/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-09-19 | GSE252321 | GEO
2024-07-23 | GSE236507 | GEO
2017-05-28 | E-MTAB-3611 | biostudies-arrayexpress
2019-10-29 | GSE128997 | GEO
2024-07-23 | GSE236506 | GEO
2017-06-06 | GSE99661 | GEO
2024-02-09 | MTBLS9131 | MetaboLights
2025-02-28 | GSE256399 | GEO
2021-06-23 | GSE157450 | GEO
2021-11-24 | GSE189294 | GEO